Dr RC Mishra

Sexy gene conversions: locating gene conversions on the X-chromosome.

This is an interesting article published in Genomics section of the journal Nucleic Acid Research by researchers at Virginia Tech.

Learning From UCLA | Science & Technology | Chemical & Engineering News.

Below is embedded a Java Applet which can help you draw Chemical Structures of your choice.

Related articles by Zemanta

• ‘Holy powder’ ingredient makes membranes behave for better health (scienceblog.com)
• Antioxidants help your body do a better job (thestar.com)
• News From The American Chemical Society , April 8, 2009 (medicalnewstoday.com)
• Turmeric The Miracle Spice (findmeacure.com)

Image via CrunchBase

TWITTER is a social networking tool that allows for real-time “micro-blogging” of short messages.

Now follow JACS’s twitter feed to stay in the loop about exciting JACS content, new features on JACS Beta, breaking news, upcoming events, and more. If you’d like to learn more about how Twitter works, please read the Twitter FAQ.

• Go to JACS’ Twitter Page for more info or connect to JACS on Twitter here
• ACS staff will be tweeting at the ACS National Meeting in Salt Lake City, March 22-26.

Reaxys, the new workflow solution for chemists, was released in January.

How can Reaxys help you as a researcher?

This innovative solution delivers exactly what you need.

• Synthesis planner: compares synthesis routes across publications and get a single overview enabling you to reach the appropriate route faster
• Superior reaction content: content from top journals and patent literature, selected by experts
• Filter and rank your search results according to preference – key properties, synthesis yield or other criteria
• Commercially available chemicals are flagged to directories (eMolecules and Symyx ACD): avoid synthesizing unnecessary compounds
• Additional search capabilities – you can generate structure queries from chemical names

Interested in more information or a free trial?
Take a look here for more details
Sincerely,
The Reaxys Team

FDA’s decision “marks the dawn of a new era in medical therapeutics,” Thomas B. Okarma, president and CEO of Geron, said during a teleconference briefing. GRNOPC1 is intended to “permanently reverse disease pathology, not merely to temporarily relieve symptoms,” he noted.

via FDA Clears Stem Cell Clinical Trial | Chemical & Engineering News: Latest News.

Related articles:

• New Prez, New Era for Stem Cells?

Mr Yadunandan, was here in Leuven for an acedemeic ceremony at facultry of Theology, KU Leuven. As I have visited ISCON Temple Radhadesh

It was the annual New Year’s Lunch Party for Rega Institute’s Med Chem Team at Groot Begijnhof.

As we were leaving after finishing our lunch, he was curious to see five indians in the team and asked, if I am from Pune (India). I told that I am from Lucknow, if he knows..He said he knows Saxena (Dr Anil Kumar Saxena, AK Saxena) there and has collaboration with around 60 labs in India. As I did my PhD from there (CDRI, Lucknow) and worked in Dr Saxena’s lab (I was working in Tripathi Research Group).

 Prof. Erik De Clercq

Bijzonder gasthoogleraar (Emeritus Professor), Department of Microbiology and Immunology

Since I came to Rega, I was very eager to see him

Purinergic signalling